<DOC>
	<DOCNO>NCT02516631</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetics two formulation misoprostol follow single dose administration adult woman give misoprostol cervical ripen induction labour .</brief_summary>
	<brief_title>Comparative Bioavailability Study Two Misoprostol Formulations</brief_title>
	<detailed_description>Prostaglandin E2 ( dinoprostone ) give vaginally intra-cervically , oxytocin commonly use preparation induction labour . Misoprostol synthetic prostaglandin E1 analogue . Misoprostol anti-secretory mucosal protective property originally develop 1970s prevention nonsteroidal anti-inflammatory drug ( NSAID ) -induced peptic ulcer . It use much widely 'off-label ' indication like medication abortion , medical management miscarriage , cervical ripen surgical procedure , treatment postpartum hemorrhage , induction labour . The lack specific license CytotecÂ® use obstetrics gynecology lead number problem regard correct dose dose regime . The study open-label , randomize , single-dose , comparative , parallel design , bioavailability study follow repeat dose two formulation misoprostol healthy adult female induce go labour . The drug shall administer orally sublingually .</detailed_description>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Adult female Women want participate give informed consent Known reach week 37 + 0 day week 42 + 2 day gestation With viable fetus vertex position Age equal 18 year old Women opt vaginal delivery BMI 20 30 kg/m2 Women know allergy misoprostol prostaglandin Women prior caesarean section Women dead anomalous fetus Women twin pregnancy Women know liver renal dysfunction</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Labour , induce</keyword>
	<keyword>Misoprostol</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Cardiotocography</keyword>
	<keyword>Safety</keyword>
</DOC>